Paul has over 25 years of specialty medical and pharmacy benefit drug and medical device industry experience, with emphasis on orphan and rare disease conditions, where he works to reduce physician and patient barriers to access. He is an established biopharmaceutical, market access, channel strategy, reimbursement, and patient – caregiver services department leader, with extensive Commercial product launch experience.

Paul has a proven track record in establishing global access strategy that considers pricing and reimbursement, Payer/PBM contracting, and public and healthcare policy – advocacy initiatives.

Paul has built and deployed multiple sales, access, provider/patient reimbursement services teams, and his focus includes Commercial readiness, tactical Access and Policy execution, and delivery on a pricing, reimbursement, and Global economic value propositions for payer, HTA, and organized system customers.

His key therapeutic experience: Orphan and Rare/Ultra-Rare Disease, CNS/Neurological (Mitochondrial, Amyloidosis, Epilepsy, Movement Disorders and Migraine), Cardiometabolic/Cardiovascular, Ophthalmology/Retinal, Urology, and Endocrinology.